Study Identifies a Mechanism behind Pancreatic Cancer Treatment Resistance
"Memoirs of Cancer" Book Now Available   - Caring About Cancer Patients
RSS Follow

Delivered by FeedBurner


Recent Posts

PANCREAS CANCER NEWS
Cervical Cancer is an International Issue
Cancer Death Rates Declining But Disparity for African Americans Still Exist
Danstock: 4 Bands 2 Raise $ 4 Cancer Research
Is a Clinical Trial Right for You?

Most Popular Posts

Sugar considered a culprit in cancer cases
Secondary Liver Cancer
The Virus HLTV-1 and Cancer
Herbs That Can Help Cancer Patients-PERIWINKLE
Antipsychotic Drug Controls "Breakthrough" Nausea and Vomiting after Chemotherapy

Categories

African American
Anal Cancer
Bladder Cancer
Brain Cancer
Breast Cancer
Breast Cancer Awareness Month
Cancer and Fertility
CANCER AND OBESITY
Cancer and Stem Cells
Cancer Care/Self-Help
CANCER EVENTS
Cancer Facts/Statistics
Cancer Information/Updates
Cancer Loss
Cancer Memories
Cancer Prevention
cancer research
Causes of cancer
Cervical cancer
Chemotherapy
Children and cancer
Clinical Trials for Cancer
colon cancer
COLORECTAL CANCER
Exciting
Head and Neck Cancer
Health Care Disparities
Help for Cancer Patient Caregivers
JOB TRAINING
Liver Cancer
LUNG CANCER
Melanoma
Metastatic Cancer
Multicultural
Multiple Myeloma Cancer
New Cancer Info.
ovarian cancer
Pancreatic Cancer
Pancreatic Cancer Awareness Month
PROSTATE CANCER
Stomach Cancer
TRIPLE NEGATIVE BREAST CANCERS

Archives

April 2013
February 2013
January 2013
December 2012
November 2012
October 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011

powered by

Caring About Cancer Patients

Study Identifies a Mechanism behind Pancreatic Cancer Treatment Resistance

Researchers have discovered a physical mechanism that prevents chemotherapy from reaching pancreatic cancer cells, as well as a way to reverse that mechanism. Dr. Sunil Hingorani of the Fred Hutchinson Cancer Research Center and his colleagues reported their results March 19 in Cancer Cell.

Pancreatic adenocarcinoma, the most common type of pancreatic cancer, is notoriously resistant to chemotherapy and radiation therapy, leading to an overall 5-year relative survival rate of less than 5 percent. Using mice with tumors that are genetically similar to human pancreatic adenocarcinomas, the researchers found that, as the tumors grow, a thick matrix develops and surrounds the tumors’ cells.

The matrix exerts tremendous pressure on the tumors—pressure that greatly exceeds the normal pressure found within blood vessels—causing the tumors’ blood vessels to collapse. This collapse prevents chemotherapy drugs in the blood stream from reaching the tumor cells.

Dr. Hingorani and his colleagues identified a substance called hyaluronic acid that forms a large part of this pressurized matrix. When they treated the mice with an enzyme called PEGPH20, which breaks down hyaluronic acid, the pressure within the tumors returned to normal, and the blood vessels regained their normal shape and function.

When the researchers treated mice with a combination of PEGPH20 and the chemotherapy drug gemcitabine, 83 percent of tumors within the pancreas shrank after only one cycle of treatment, and all tumors shrank after three cycles. Similar responses were seen in metastatic tumors. Mice that received the combination therapy survived almost twice as long as mice that received PEGPH20 plus a placebo.

“When able to penetrate the tumor bed, gemcitabine can indeed be an effective agent against this disease,” wrote the authors. An early phase clinical trial is testing the combination of PEGPH20 and gemcitabine in people with metastatic pancreatic cancer.

0 Comments to Study Identifies a Mechanism behind Pancreatic Cancer Treatment Resistance:

Comments RSS

Add a Comment

Your Name:
Email Address: (Required)
Website:
Comment:
Make your text bigger, bold, italic and more with HTML tags. We'll show you how.
Post Comment